These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11152513)

  • 1. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner.
    Majumder M; Ghosh AK; Steele R; Ray R; Ray RB
    J Virol; 2001 Feb; 75(3):1401-7. PubMed ID: 11152513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.
    Lan KH; Sheu ML; Hwang SJ; Yen SH; Chen SY; Wu JC; Wang YJ; Kato N; Omata M; Chang FY; Lee SD
    Oncogene; 2002 Jul; 21(31):4801-11. PubMed ID: 12101418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding.
    Gong GZ; Jiang YF; He Y; Lai LY; Zhu YH; Su XS
    World J Gastroenterol; 2004 Aug; 10(15):2223-7. PubMed ID: 15259070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3.
    Kwun HJ; Jung EY; Ahn JY; Lee MN; Jang KL
    J Gen Virol; 2001 Sep; 82(Pt 9):2235-2241. PubMed ID: 11514734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional repression of p21(waf1) promoter by hepatitis B virus X protein via a p53-independent pathway.
    Ahn JY; Chung EY; Kwun HJ; Jang KL
    Gene; 2001 Sep; 275(1):163-8. PubMed ID: 11574165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3.
    Qadri I; Iwahashi M; Simon F
    Biochim Biophys Acta; 2002 Oct; 1592(2):193-204. PubMed ID: 12379483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability.
    Otsuka M; Kato N; Lan K; Yoshida H; Kato J; Goto T; Shiratori Y; Omata M
    J Biol Chem; 2000 Nov; 275(44):34122-30. PubMed ID: 10924497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein.
    Koutsodontis G; Tentes I; Papakosta P; Moustakas A; Kardassis D
    J Biol Chem; 2001 Aug; 276(31):29116-25. PubMed ID: 11384995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter.
    Zhang W; Geiman DE; Shields JM; Dang DT; Mahatan CS; Kaestner KH; Biggs JR; Kraft AS; Yang VW
    J Biol Chem; 2000 Jun; 275(24):18391-8. PubMed ID: 10749849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21(WAF1) down-regulation -- effect of transforming growth factor beta.
    Dubourdeau M; Miyamura T; Matsuura Y; Alric L; Pipy B; Rousseau D
    J Hepatol; 2002 Oct; 37(4):486-92. PubMed ID: 12217602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UV radiation is a transcriptional inducer of p21(Cip1/Waf1) cyclin-kinase inhibitor in a p53-independent manner.
    Haapajärvi T; Kivinen L; Heiskanen A; des Bordes C; Datto MB; Wang XF; Laiho M
    Exp Cell Res; 1999 Apr; 248(1):272-9. PubMed ID: 10094833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The repressive activity of hepatitis C virus core protein on the transcription of p21(waf1) is regulated by protein kinase A-mediated phosphorylation.
    Jung EY; Lee MN; Yang HY; Yu D; Jang KL
    Virus Res; 2001 Nov; 79(1-2):109-15. PubMed ID: 11551651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
    Lin J; Zhu MH; Qu JH; Li FM; Ni CR
    Ai Zheng; 2004 Jul; 23(7):749-55. PubMed ID: 15248906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulation mechanism of HCV NS5A on p53 protein transactivity].
    Gong GZ; Jiang YF; Zhu YH; Su XS
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):162-5. PubMed ID: 12681065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
    Chowdhury IH; Farhadi A; Wang XF; Robb ML; Birx DL; Kim JH
    Int J Cancer; 2003 Nov; 107(4):603-11. PubMed ID: 14520699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization.
    Akashi M; Osawa Y; Koeffler HP; Hachiya M
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):607-16. PubMed ID: 9895308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.
    Weinberg WC; Montano NE; Deng C
    Oncogene; 1997 Aug; 15(6):685-90. PubMed ID: 9264409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines.
    Siavoshian S; Abraham JD; Kieny MP; Schuster C
    Arch Virol; 2004 Feb; 149(2):323-36. PubMed ID: 14745598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.